Mitochondrial quality control is maintained by coordinated turnover mechanisms involving mitophagy (removal of damaged mitochondria) and mitochondrial biogenesis (generation of new mitochondria). Disruption of either one or both processes results in the accumulation of damaged mitochondria, oxidative stress and subsequently impaired cellular function. In human airway smooth muscle (hASM) cells, such impairment compromises sustained ATP production required for contractile responses. A key regulator of this balance is PARIS (ZNF746), a transcriptional repressor of PGC1α. Accumulated PARIS binds upstream to the promoter of PGC1α and interferes with the recruitment of transcriptional activators, resulting in decreased PGC1α transcription and reduced mitochondrial biogenesis. In addition, PARIS is implicated in the disruption of cellular antioxidant defense mechanisms due to its direct interaction with NRF2 transcriptional complex. Under basal conditions, PARIS levels are tightly regulated by post-translational modifications such as ubiquitination and phosphorylation. As a target of PINK1/pParkinS65 mediated mitophagy, pParkinS65 binds to PARIS, catalyzing its ubiquitination and proteasomal degradation, thereby alleviating its transcriptional repression of PGC1α and NRF2 and promoting mitochondrial biogenesis. Furthermore, evidence indicates that NRF2 transcriptionally regulates PINK1 expression during oxidative stress and amplifies mitophagy. Therefore, we hypothesize that mitochondrial turnover mechanisms can be regulated by targeting PARIS. In the present study, primary hASM cells were isolated from bronchiolar tissue of 6 patients with no history of chronic pulmonary disease or smoking. The hASM cells were phenotyped and separated into two treatment groups: 1) FCCP (1 µM, 6 h; positive control), a proton ionophore that induces mitochondrial depolarization (damage); 2) untreated control. We observed that FCCP induced extensive mitochondrial membrane depolarization, assessed by changes in mitochondrial membrane potential (Ψm) using TMRM (250 nM). Increased mitochondrial damage was observed with FCCP, measured by the extent of co-labeling of MitoTracker Red FM (200 nM) and CellLight Mitochondria-GFP. Mitochondrial turnover was also quantified by confocal imaging of hASM cells transfected with pMitoTimer, a fluorescent reporter protein in which fluorescence shifts over time from green (Excitation/Emission-488 nm/518 nm) to red (Excitation/Emission-543 nm/572 nm) when oxidized due to mitochondrial stress. Ratiometric analysis of pMitoTimer revealed significant shift from green to red fluorescence with FCCP and accumulation of pure red fluorescent puncta indicative of damaged mitochondria. FCCP increased PINK1 recruitment to mitochondria and increased pParkinS65 and ubiquitin (pUbS65) phosphorylation. Total PARIS accumulation decreased due to increased PARIS ubiquitination, as measured by immunoprecipitation. As a result, PGC1α and downstream NRF2 mRNA and protein expression, as well as mtDNA copy number were increased, indicative of increased mitochondrial biogenesis. Bioinformatics analysis and chromatin immunoprecipitation (ChIP) assay using an NRF2-specific antibody revealed that NRF2 binds to the promoter of PINK1, with FCCP further increasing the binding, thereby increasing PINK1 expression and enhancing mitophagy. Together, these findings identify the PARIS-NRF2 axis as a promising target to mitigate oxidative stress and maintain mitochondrial homeostasis in hASM cells. Supported by NIH grants HL157984 (GCS) and AG44615 (GCS) This abstract was presented at the American Physiology Summit 2026 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
Bhat et al. (Fri,) studied this question.